Drugs / ATS907
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01520116 | Jan → Dec 2012 | ocular hypertension, open-angle glaucoma | Altheos, Inc. | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01668524 | Aug 2012 | ocular hypertension, open-angle glaucoma | Altheos, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATS907 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01668524 ↗ |